Skilled Nursing Facility at Home Trial
Skilled Nursing Facility at Home is a multicenter randomized control trial that aims to evaluate a home-based model of providing post-acute care (PAC). We will enroll 650 hospitalized patients who require rehabilitation and/or skilled-nursing support upon discharge and randomly assign them to an intervention (home-base
| Condition(s) | Skilled Nursing Facility, Rehabilitation, Home Based Care |
|---|---|
| Status | Recruiting |
| Phase | NA |
| Study type | Interventional |
| Summary | Skilled Nursing Facility at Home is a multicenter randomized control trial that aims to evaluate a home-based model of providing post-acute care (PAC). We will enroll 650 hospitalized patients who require rehabilitation and/or skilled-nursing support upon discharge and randomly assign them to an intervention (home-based PAC) or control arm (facility-based PAC). Our design includes two different health systems in Massachusetts: Baystate Health and UMass Memorial Health. We will perform 1:1 randomization between the intervention and control arm using a permuted block design, with stratification by clinical site and payor group. The primary outcome of the trial will be the difference in hospital readmission and mortality rates from the time of enrollment to 30 days after enrollment. Secondary |
| Who can participate | Inclusion Criteria: * Age 18 or older * Admitted to an inpatient unit OR receiving home health and requiring an escalation to skilled-nursing facility care * Require post-acute care in a skilled nursing facility based on the clinical inpatient team's assessment (or, if the participant is coming from home, based on the home health team's assessment) * Pass the home readiness assessment * Reside within Greater Worcester or Greater Springfield Exclusion Criteria: * Inability to return to a home residence where care can be provided * Inability for patient or their proxy to provide informed consent for the study * Requires long-term care * Requires palliative or hospice care * On active chemotherapy * Post-transplant surgery * Requires hemodialysis * Requires radiation therapy * Requires two-pe |
| Ages | 18 Years |
| Sex | All |
| Lead sponsor | University of Massachusetts, Worcester |
| Locations | Springfield, Massachusetts, United States; Worcester, Massachusetts, United States |
| Start date | 2024-08-26 |
| NCT ID | NCT06547645 |
| Official listing | https://clinicaltrials.gov/study/NCT06547645 |